You're all set! 🎉

Thanks for subscribing. Your plan is now active and every feature on it is unlocked. We've also sent a confirmation to your email.

You're all set! 🎉

Thanks for subscribing. Your plan is now active and every feature on it is unlocked. We've also sent a confirmation to your email.

SCTX

Scribe Therapeutics, Inc.

Manufacturing

Pharmaceutical Products

XNAS

20.40

4.64

25.27%

Jul 30, 3:59 PM EDT

O 18.79H 20.68L 19.49C 20.64Vol 112.96K

Jul 30, 2026

Scribe Therapeutics, Inc.

We are a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed to extend healthy lifespan through disease prevention and durable therapeutic intervention.

Sector

Manufacturing

Theme

Unknown theme

Industry

Pharmaceutical Products

Date listed

Fri, Jul 24, 2026

Employees

Currency

usd

Shares outstanding

Locale

Shares float

Type

Market cap.

P/E (realtime)

Primary exchange

XNAS

CIK

0001853921

Website

www.scribetx.com

Recent news relating to SCTX

No recent news for SCTX